Cargando…

Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales: Zhang, Linmeng, Tang, Ning, Yang, Chen, Geng, Haigang, Hang, Hualian, Qin, Wenxin, Wang, Cun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911634/
https://www.ncbi.nlm.nih.gov/pubmed/36759503
http://dx.doi.org/10.1038/s41392-022-01262-x
_version_ 1784885029577424896
author Zhang, Linmeng
Tang, Ning
Yang, Chen
Geng, Haigang
Hang, Hualian
Qin, Wenxin
Wang, Cun
author_facet Zhang, Linmeng
Tang, Ning
Yang, Chen
Geng, Haigang
Hang, Hualian
Qin, Wenxin
Wang, Cun
author_sort Zhang, Linmeng
collection PubMed
description
format Online
Article
Text
id pubmed-9911634
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-99116342023-02-11 Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma Zhang, Linmeng Tang, Ning Yang, Chen Geng, Haigang Hang, Hualian Qin, Wenxin Wang, Cun Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-02-10 /pmc/articles/PMC9911634/ /pubmed/36759503 http://dx.doi.org/10.1038/s41392-022-01262-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Zhang, Linmeng
Tang, Ning
Yang, Chen
Geng, Haigang
Hang, Hualian
Qin, Wenxin
Wang, Cun
Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma
title Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma
title_full Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma
title_fullStr Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma
title_full_unstemmed Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma
title_short Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma
title_sort combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911634/
https://www.ncbi.nlm.nih.gov/pubmed/36759503
http://dx.doi.org/10.1038/s41392-022-01262-x
work_keys_str_mv AT zhanglinmeng combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma
AT tangning combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma
AT yangchen combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma
AT genghaigang combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma
AT hanghualian combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma
AT qinwenxin combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma
AT wangcun combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma